HKSTP

X-PITCH 2022 Winners Announced in the Metaverse

Retrieved on: 
木曜日, 11月 10, 2022

10 startups emerged as award winners and the top 3 startups will receive US$1 million investment in total.

Key Points: 
  • 10 startups emerged as award winners and the top 3 startups will receive US$1 million investment in total.
  • Heres the winners list:
    This press release features multimedia.
  • X-PITCH 2022 is the first large-scale startup contest in Asia held in the Metaverse.
  • Venu is proud to be chosen to deliver an unparalleled metaverse experience for X-PITCH, a prestigious startup and investor network.

Pantheon Lab Raises Seed Funding Led by Alibaba Hong Kong Entrepreneurs Fund to Grow its AI-Powered Digital Humans

Retrieved on: 
木曜日, 11月 10, 2022

HONG KONG, Nov. 9, 2022 /PRNewswire/ --Pantheon Lab Limited, Hong Kong's leading deep-learning start-up, announced today that it has raised seed funding led by Alibaba Hong Kong Entrepreneurs Fund (AEF), managed by Gobi Partners GBA.

Key Points: 
  • HONG KONG, Nov. 9, 2022 /PRNewswire/ --Pantheon Lab Limited, Hong Kong's leading deep-learning start-up, announced today that it has raised seed funding led by Alibaba Hong Kong Entrepreneurs Fund (AEF), managed by Gobi Partners GBA.
  • Since the company's official market debut in April 2022, Pantheon Lab has led the way in AI-driven synthetic media, placing it at the forefront of face-shifting technology andcreatingground-breaking human-likeness in the digital sphere.
  • Pantheon Lab is a Deep-Learning start-up founded in 2019 and a member company of the Inch-Tech Programme, HKSTP.
  • In 2022, Pantheon Lab launched its first digital human ecosystem AIDOL, building life-like quality digital humans with emotions and converse like a human.

Pantheon Lab Raises Seed Funding Led by Alibaba Hong Kong Entrepreneurs Fund to Grow its AI-Powered Digital Humans

Retrieved on: 
木曜日, 11月 10, 2022

HONG KONG, Nov. 10, 2022 /PRNewswire/ --Pantheon Lab Limited, Hong Kong's leading deep-learning start-up, announced today that it has raised seed funding led by Alibaba Hong Kong Entrepreneurs Fund (AEF), managed by Gobi Partners GBA.

Key Points: 
  • HONG KONG, Nov. 10, 2022 /PRNewswire/ --Pantheon Lab Limited, Hong Kong's leading deep-learning start-up, announced today that it has raised seed funding led by Alibaba Hong Kong Entrepreneurs Fund (AEF), managed by Gobi Partners GBA.
  • Since the company's official market debut in April 2022, Pantheon Lab has led the way in AI-driven synthetic media, placing it at the forefront of face-shifting technology andcreatingground-breaking human-likeness in the digital sphere.
  • Pantheon Lab is a Deep-Learning start-up founded in 2019 and a member company of the Inch-Tech Programme, HKSTP.
  • In 2022, Pantheon Lab launched its first digital human ecosystem AIDOL, building life-like quality digital humans with emotions and converse like a human.

THE 3RD ANNUAL TADS AWARDS ANNOUNCES 2022 WINNERS AND RISING STARS FOR "BEST OF CLASS TADS," "ECOSYSTEM EXCELLENCE" AND "NFT INNOVATIONS"

Retrieved on: 
金曜日, 11月 4, 2022

We are very delighted to receive an overwhelming response in terms of numbers and quality of nominees this year at the 3rd TADS Awards.

Key Points: 
  • We are very delighted to receive an overwhelming response in terms of numbers and quality of nominees this year at the 3rd TADS Awards.
  • TADS Awards is co-organized by Asia Pacific Digital Economy Institute, Coinstreet Partners, and DAS (Digital Asset Series) Seminars.
  • For more information about TADS Awards and results from the previous years, please visit https://tadsawards.org/ .
  • Over the past years, Coinstreet has helped 20+ Blockchain, Digital Asset and FinTech projects in the global market.

HKSTP Elevator Pitch Competition 2023 Invites Global Innovators to Tap into Hong Kong’s Boundless Investment and Asia Expansion Opportunities

Retrieved on: 
木曜日, 10月 27, 2022

Hong Kong Science and Technology Parks Corporation (HKSTP) today kicked off its seventh global Elevator Pitch Competition 2023 (EPiC 2023), by inviting tech startups around the world to enter one of the largest elevator pitch events in Hong Kong.

Key Points: 
  • Hong Kong Science and Technology Parks Corporation (HKSTP) today kicked off its seventh global Elevator Pitch Competition 2023 (EPiC 2023), by inviting tech startups around the world to enter one of the largest elevator pitch events in Hong Kong.
  • EPiC 2023 is a unique platform that connects entrepreneurs to investors, corporate partners and Hong Kongs biggest innovation and technology ecosystem.
  • HKSTP aims to continue nurturing talent and providing a unique platform for local and international innovators to unlock growth and global opportunities.
  • The Top 50 semi-finalists all qualify for a chance to secure up to US$5 million investment by the HKSTP Venture Fund.

World Artificial Intelligence Conference 2022 - Hong Kong Branch Concludes with Great Success

Retrieved on: 
木曜日, 9月 1, 2022

Organised by the Innovation and Technology Commission (ITC) with the Hong Kong Science and Technology Parks Corporation (HKSTP) as organising partner, the World Artificial Intelligence Conference (WAIC) 2022 - Hong Kong Branch was successfully held at Hong Kong Science Park today (September 1).

Key Points: 
  • Organised by the Innovation and Technology Commission (ITC) with the Hong Kong Science and Technology Parks Corporation (HKSTP) as organising partner, the World Artificial Intelligence Conference (WAIC) 2022 - Hong Kong Branch was successfully held at Hong Kong Science Park today (September 1).
  • It clearly supports Hong Kong to develop into an international innovation and technology (I&T) centre and presents historic opportunities for Hong Kong.
  • In the welcoming remarks, the Commissioner for Innovation and Technology, Ms Rebecca Pun, thanked the WAIC for its invitation to host the Hong Kong Branch.
  • The Chief Executive Officer of the HKSTP, Mr Albert Wong, said, "The HKSTP is deeply honoured to co-organise with the ITC the WAIC 2022 - Hong Kong Branch, which is a great showcase of Hong Kong's AI innovation and talents.

HKSTP Celebrates 20 Years of Propelling Success and Innovation

Retrieved on: 
月曜日, 7月 11, 2022

HONG KONG, July 11, 2022 /PRNewswire/ -- Hong Kong Science and Technology Parks Corporation (HKSTP) is celebrating its 20th anniversary of propelling success and innovation and is set for a new chapter of growth for Hong Kong powered by the Central Government's support on Innovation & Technology (I&T), the Greater Bay Area (GBA) and young generation of talent that goes beyond borders.

Key Points: 
  • Mr Albert Wong, CEO, HKSTP, said: "The visit by President Xi on June 30 was a historic moment for HKSTP.
  • Talent is the critical foundation for innovation success and HKSTP has built up Hong Kong's largest R&D community of 17,000 people, of which 11,000 are research and development professionals.
  • HKSTP is opening a new chapter of growth for Hong Kong, built on Innovation, Technology and Industrialisation as the critical new pillar of the economy.
  • Hong Kong Science and Technology Parks Corporation (HKSTP) has for 20 continuous years committed to building up Hong Kong as an international innovation and technology hub to propel success for local and global pioneers today and tomorrow.

SinoMab Received the Highest Subsidy from HKSTP

Retrieved on: 
金曜日, 7月 8, 2022

Under this program, funding support will be provided to biomedical companies of HKSTP to bring innovative, life-changing therapies and technologies to patients.

Key Points: 
  • Under this program, funding support will be provided to biomedical companies of HKSTP to bring innovative, life-changing therapies and technologies to patients.
  • SinoMab stood out from many biopharmaceutical companies in the CTC program and was granted the highest subsidy amount, embodying the recognition by the evaluation committee on the Company's product candidates and research and development (R&D) plan.
  • Dr. Shui On LEUNG, Chairman, Executive Director and Chief Executive Officer of SinoMab said that: "By launching the CTC program, HKSTP provides great support to local biopharmaceutical companies on their New Drug R&D.
  • With the smooth progress of clinical trials of the Company's key candidates, the subsidy from the HKSTP will provide a solid foundation for the Company's continuous R&D and stepping toward commercialization.

X-PITCH 2022 is Open for Applications

Retrieved on: 
金曜日, 7月 1, 2022

3,680 startups from 42 countries and over 28,000 ecosystem stakeholders participated in X-PITCH 2021, which has become one of the largest startup contests in Asia.

Key Points: 
  • 3,680 startups from 42 countries and over 28,000 ecosystem stakeholders participated in X-PITCH 2021, which has become one of the largest startup contests in Asia.
  • The event is also supported by global partners including e27, E-Mobility Global Demo Day, Equidam, SLINGSHOT 2022, and Technode Global.
  • The TECH FOR GOOD theme of X-PITCH 2022 highlights the challenges in the post-pandemic world and innovations that will make meaningful social impacts for the public good.
  • Participating teams should focus on applications and services that accelerate digital transformation around five major categories, backed by Web3, AI, 5G, edge computing and next-gen technologies.

HKSTP and Boehringer Ingelheim Venture Fund Launch Co-Incubation Programme to Fast-track R&D in Infectious Diseases and Immunology

Retrieved on: 
金曜日, 6月 17, 2022

Both local and global qualified startups in infectious diseases and immunology can apply to the incubation programme to access the full capabilities of the HKSTP ecosystem and BIVFs extensive biotech funding network.

Key Points: 
  • Both local and global qualified startups in infectious diseases and immunology can apply to the incubation programme to access the full capabilities of the HKSTP ecosystem and BIVFs extensive biotech funding network.
  • We look forward to developing together with HKSTP next-generation therapies in the fields of infectious diseases and immunology with long term partnerships.
  • Created in 2010, the Boehringer Ingelheim Venture Fund GmbH (BIVF) invests in groundbreaking therapeutics-focused biotechnology companies to drive innovation in biomedical research.
  • Established in 2020, Boehringer Ingelheim External Innovation Hub China unites three external innovation functions including Research Beyond Borders (RBB), Business Development & Licensing (BD&L) and the Boehringer Ingelheim Venture Fund (BIVF).